Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedJul 21, 2024
DataAggregated Company Financials
Companies32
  • 7D-2.6%
  • 3M30.8%
  • 1Y75.7%
  • YTD17.6%

Over the last 7 days, the Pharma industry has dropped 2.6%, driven by Camurus declining 3.4%. This takes the industry's 12 month performance to a gain of 75%. Earnings are forecast to grow by 66% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 21 Jul 2024SEK 67.0bSEK 5.5b-SEK 997,468,990.47111.3x-67.2x12.1x
Tue, 18 Jun 2024SEK 63.0bSEK 6.4b-SEK 862,367,810.9872.7x-73.1x9.9x
Thu, 16 May 2024SEK 53.9bSEK 6.4b-SEK 803,380,874.4972.5x-67.1x8.5x
Sat, 13 Apr 2024SEK 51.3bSEK 6.2b-SEK 1,040,626,304.1977.9x-49.3x8.2x
Mon, 11 Mar 2024SEK 50.1bSEK 6.2b-SEK 1,038,035,434.2277.2x-48.3x8x
Wed, 07 Feb 2024SEK 53.7bSEK 6.0b-SEK 933,087,764.6468.8x-57.6x9x
Fri, 05 Jan 2024SEK 69.9bSEK 9.4b-SEK 1,184,285,567.0065.5x-59.1x7.4x
Sun, 03 Dec 2023SEK 62.4bSEK 9.5b-SEK 1,209,395,296.0057.1x-51.6x6.6x
Tue, 31 Oct 2023SEK 52.7bSEK 9.3b-SEK 1,115,141,257.0082.4x-47.3x5.7x
Thu, 28 Sep 2023SEK 51.6bSEK 9.2b-SEK 1,177,268,634.00134.6x-43.8x5.6x
Sat, 26 Aug 2023SEK 50.3bSEK 9.2b-SEK 1,136,339,447.0079.3x-44.2x5.5x
Mon, 24 Jul 2023SEK 51.1bSEK 8.8b-SEK 1,370,082,854.0076.5x-37.3x5.8x
Wed, 21 Jun 2023SEK 48.2bSEK 8.4b-SEK 1,693,123,293.0074.4x-28.5x5.8x
Fri, 19 May 2023SEK 47.8bSEK 8.4b-SEK 1,755,023,085.0080.6x-27.2x5.7x
Sun, 16 Apr 2023SEK 46.1bSEK 8.0b-SEK 1,795,014,667.0090.4x-25.7x5.8x
Tue, 14 Mar 2023SEK 45.3bSEK 8.0b-SEK 1,793,858,804.0088.4x-25.3x5.7x
Thu, 09 Feb 2023SEK 48.4bSEK 7.3b-SEK 1,966,280,978.00279.4x-24.6x6.6x
Sat, 07 Jan 2023SEK 47.5bSEK 7.3b-SEK 1,910,941,792.00294.7x-24.9x6.5x
Mon, 05 Dec 2022SEK 50.3bSEK 8.7b-SEK 10,980,827,949.00296.6x-4.6x5.8x
Wed, 02 Nov 2022SEK 48.9bSEK 7.0b-SEK 1,757,161,103.0044.1x-27.8x7x
Fri, 30 Sep 2022SEK 49.4bSEK 7.0b-SEK 1,739,825,876.0047.2x-28.4x7.1x
Sun, 28 Aug 2022SEK 51.5bSEK 7.0b-SEK 1,780,743,144.0059x-28.9x7.4x
Tue, 26 Jul 2022SEK 50.7bSEK 6.6b-SEK 1,611,454,342.0041.8x-31.5x7.7x
Thu, 23 Jun 2022SEK 50.6bSEK 5.9b-SEK 1,509,116,648.0043.4x-33.6x8.6x
Sat, 21 May 2022SEK 52.2bSEK 5.7b-SEK 1,370,760,761.0045.5x-38.1x9.2x
Mon, 18 Apr 2022SEK 56.8bSEK 5.5b-SEK 1,335,346,728.0038.8x-42.5x10.3x
Wed, 16 Mar 2022SEK 49.8bSEK 5.4b-SEK 1,389,013,613.0033.9x-35.9x9.2x
Fri, 11 Feb 2022SEK 53.0bSEK 5.3b-SEK 1,056,814,318.00151x-50.1x10x
Sun, 09 Jan 2022SEK 55.5bSEK 5.5b-SEK 1,100,207,955.00125.4x-50.5x10.2x
Tue, 07 Dec 2021SEK 54.5bSEK 5.5b-SEK 1,097,731,768.00120.8x-49.6x10x
Thu, 04 Nov 2021SEK 52.1bSEK 5.0b-SEK 1,472,230,867.00134.3x-35.4x10.4x
Sat, 02 Oct 2021SEK 53.9bSEK 4.8b-SEK 1,582,413,250.00159.8x-34.1x11.3x
Mon, 30 Aug 2021SEK 57.1bSEK 4.8b-SEK 1,413,242,854.26161.1x-40.4x11.9x
Price to Earnings Ratio

-38.4x


Total Market Cap: SEK 54.2bTotal Earnings: -SEK 1,412,039,942.26Total Revenue: SEK 4.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -40.4x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.0x is lower than the industry's current PS ratio of 12.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 5.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.84%
Healthcare0.80%
Pharma-2.59%
Pharma-2.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FLERIE FlerieSEK 48.132.8%
+SEK 102.3m		n/an/a
ERMA Enorama PharmaSEK 5.3282.2%
+SEK 98.2m		60.7%PS325x
ANNX Annexin PharmaceuticalsSEK 0.8715.7%
+SEK 62.9m		-4.6%PB12.8x
CALTX Calliditas TherapeuticsSEK 206.400.3%
+SEK 37.1m		138.3%PS8.5x
MOB Moberg PharmaSEK 38.462.1%
+SEK 36.4m		482.7%PS2190x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ENZY

SEK 2.00

Enzymatica

7D

-24.8%

1Y

-30.4%

ORX

SEK 16.48

Orexo

7D

-17.6%

1Y

-13.4%

Orexo AB (publ) (STO:ORX) Just Reported Earnings, And Analysts Cut Their Target Price

Jul 20
Orexo AB (publ) (STO:ORX) Just Reported Earnings, And Analysts Cut Their Target Price

CAMX

SEK 636.00

Camurus

7D

-3.4%

1Y

108.1%

ANNX

SEK 0.87

Annexin Pharmaceuticals

7D

15.7%

1Y

-4.6%

CALTX

SEK 206.40

Calliditas Therapeutics

7D

0.3%

1Y

138.3%

STABL

SEK 0.73

Stayble Therapeutics

7D

36.1%

1Y

-65.3%

CSMED

DKK 6.03

CS Medica

7D

26.8%

1Y

-22.3%

FLERIE

SEK 48.13

Flerie

7D

2.8%

1Y

n/a

CINPHA

SEK 32.80

Cinclus Pharma Holding

7D

-4.1%

1Y

n/a

CESSA

DKK 7.02

Cessatech

7D

6.4%

1Y

264.7%

MOB

SEK 38.46

Moberg Pharma

7D

2.1%

1Y

482.7%

ODI

SEK 5.40

ODI Pharma

7D

-15.6%

1Y

-2.7%

ERMA

SEK 5.32

Enorama Pharma

7D

82.2%

1Y

60.7%

IBT B

SEK 99.40

Infant Bacterial Therapeutics

7D

-1.6%

1Y

10.4%

SECARE

SEK 50.15

Swedencare

7D

-6.8%

1Y

7.4%

PILA

SEK 5.80

Pila Pharma

7D

-31.8%

1Y

126.6%